Total Payments
$11,908
2023 Payments
$108.64
Companies
7
Transactions
16
Medicare Patients
192
Medicare Billing
$28,481
Payment Breakdown by Category
Consulting$6,600 (55.4%)
Other$3,255 (27.3%)
Travel$1,761 (14.8%)
Food & Beverage$291.75 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,600 | 1 | 55.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,255 | 3 | 27.3% |
| Travel and Lodging | $1,761 | 6 | 14.8% |
| Food and Beverage | $291.75 | 6 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Purdue Pharma L.P. | $11,617 | 10 | $0 (2017) |
| Novo Nordisk Inc | $81.84 | 1 | $0 (2023) |
| RedHill Biopharma Inc. | $70.50 | 1 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $53.85 | 1 | $0 (2022) |
| GRT US Holding, Inc. | $45.00 | 1 | $0 (2022) |
| Ferring Pharmaceuticals Inc. | $26.80 | 1 | $0 (2023) |
| Daiichi Sankyo Inc. | $13.76 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $108.64 | 2 | Novo Nordisk Inc ($81.84) |
| 2022 | $98.85 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($53.85) |
| 2021 | $70.50 | 1 | RedHill Biopharma Inc. ($70.50) |
| 2019 | $13.76 | 1 | Daiichi Sankyo Inc. ($13.76) |
| 2017 | $11,617 | 10 | Purdue Pharma L.P. ($11,617) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/27/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $81.84 | General |
| 05/19/2023 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: ORTHOPEDICS | ||||||
| 09/08/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $53.85 | General |
| Category: Gastroenterology | ||||||
| 09/06/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: Pain Management | ||||||
| 09/07/2021 | RedHill Biopharma Inc. | MOVANTIK (Drug) | Food and Beverage | Cash or cash equivalent | $70.50 | General |
| Category: Opioid Antagonist | ||||||
| 02/18/2019 | Daiichi Sankyo Inc. | Morphabond ER (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Pain Management | ||||||
| 11/02/2017 | Purdue Pharma L.P. | HYSINGLA ER (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,640.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/02/2017 | Purdue Pharma L.P. | HYSINGLA ER (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/02/2017 | Purdue Pharma L.P. | HYSINGLA ER (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $65.20 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/09/2017 | Purdue Pharma L.P. | HYSINGLA ER (Drug) | Consulting Fee | Cash or cash equivalent | $6,600.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/10/2017 | Purdue Pharma L.P. | HYSINGLA ER (Drug) | Travel and Lodging | Cash or cash equivalent | $164.04 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/10/2017 | Purdue Pharma L.P. | HYSINGLA ER (Drug) | Travel and Lodging | Cash or cash equivalent | $98.42 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/09/2017 | Purdue Pharma L.P. | HYSINGLA ER (Drug) | Travel and Lodging | Cash or cash equivalent | $163.30 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/09/2017 | Purdue Pharma L.P. | HYSINGLA ER (Drug) | Travel and Lodging | Cash or cash equivalent | $98.42 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/09/2017 | Purdue Pharma L.P. | HYSINGLA ER (Drug) | Travel and Lodging | Cash or cash equivalent | $96.74 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/05/2017 | Purdue Pharma L.P. | HYSINGLA ER (Drug) | Travel and Lodging | Cash or cash equivalent | $1,140.40 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 58 | 191 | $31,971 | $8,895 |
| 2021 | 3 | 66 | 216 | $35,749 | $9,206 |
| 2020 | 3 | 68 | 259 | $40,324 | $10,379 |
Total Patients
192
Total Services
666
Medicare Billing
$28,481
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 94 | $15,510 | $5,808 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 21 | $5,061 | $1,934 | 38.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 23 | 76 | $11,400 | $1,153 | 10.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 108 | $17,820 | $6,116 | 34.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 19 | $4,579 | $1,694 | 37.0% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 27 | 89 | $13,350 | $1,396 | 10.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 28 | 136 | $21,080 | $6,913 | 32.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 27 | $5,804 | $2,021 | 34.8% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 28 | 96 | $13,440 | $1,445 | 10.8% |
About Dr. William Doss, M.D
Dr. William Doss, M.D is a Pain Medicine healthcare provider based in Bryan, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710950308.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Doss, M.D has received a total of $11,908 in payments from pharmaceutical and medical device companies, with $108.64 received in 2023. These payments were reported across 16 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($6,600).
As a Medicare-enrolled provider, Doss has provided services to 192 Medicare beneficiaries, totaling 666 services with total Medicare billing of $28,481. Data is available for 3 years (2020–2022), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Physical Medicine & Rehabilitation, Pain Medicine
- Location Bryan, TX
- Active Since 02/13/2006
- Last Updated 02/05/2026
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1710950308
Products in Payments
- HYSINGLA ER (Drug) $11,617
- MOVANTIK (Drug) $70.50
- RELISTOR (Drug) $53.85
- Qutenza (Drug) $45.00
- EUFLEXXA (Device) $26.80
- Morphabond ER (Drug) $13.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.